Business Description
Sai Life Sciences Ltd
ISIN : INE570L01029
Compare
Compare
Traded in other countries / regions
SAILIFE.India IPO Date
2024-12-18Description
Sai Life Sciences Ltd is an innovator-focused, contract research, development, and manufacturing organization. It provide end to-end services across the drug discovery, development, and manufacturing value chain, for small molecule new chemical entities (NCE), to pharmaceutical innovator companies and biotechnology firms. It possess both (a) discovery/contract research (CRO) and (b) chemistry, manufacturing, and control (CMC)/contract development and manufacturing organization (CDMO) capabilities. The company has only one reportable segment namely Contract research, development and manufacturing.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.21 | |||||
| Equity-to-Asset | 0.42 | |||||
| Debt-to-Equity | 0.95 | |||||
| Debt-to-EBITDA | N/A |
N/A
|
N/A
| |||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 33.16 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.22 | |||||
| Quick Ratio | 1.1 | |||||
| Cash Ratio | 0.25 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | 5.54 | |||||
| Years of Profitability over Past 10-Year | 3 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | N/A |
N/A
|
N/A
| |||
| PE Ratio without NRI | N/A |
N/A
|
N/A
| |||
| PS Ratio | 10.23 | |||||
| PB Ratio | 14.37 | |||||
| Price-to-Tangible-Book | 14.54 | |||||
| Price-to-Free-Cash-Flow | 184.48 | |||||
| Price-to-Operating-Cash-Flow | 57.08 | |||||
| EV-to-EBIT | 80.96 | |||||
| EV-to-EBITDA | 50.22 | |||||
| EV-to-Revenue | 10.76 | |||||
| EV-to-FCF | 194.09 | |||||
| Earnings Yield (Greenblatt) % | 1.24 | |||||
| FCF Yield % | 0.54 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sai Life Sciences Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 14,687.23 | ||
| EPS (TTM) (₹) | 0 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (₹) | 0 | ||
| 20-Day SMA (₹) | 0 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (₹) | 650 - 808.8 | ||
| Shares Outstanding (Mil) | 207.99 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sai Life Sciences Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sai Life Sciences Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sai Life Sciences Ltd Frequently Asked Questions
What is Sai Life Sciences Ltd(NSE:SAILIFE)'s stock price today?
The current price of NSE:SAILIFE is ₹722.05. The 52 week high of NSE:SAILIFE is ₹808.80 and 52 week low is ₹650.00.
When is next earnings date of Sai Life Sciences Ltd(NSE:SAILIFE)?
The next earnings date of Sai Life Sciences Ltd(NSE:SAILIFE) is .
Does Sai Life Sciences Ltd(NSE:SAILIFE) pay dividends? If so, how much?
Sai Life Sciences Ltd(NSE:SAILIFE) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers